🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › Louisiana

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Louisiana

Tha 6 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann an Louisiana.

Bailtean ann an Louisiana

Teacsa sgrùdaidh oifigeil (Beurla)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • CHRISTUS St. Frances Cabrini Hospital Center for Cancer Care ( Site 0109), Alexandria
  • Louisiana State University Health Sciences Shreveport ( Site 0029), Shreveport
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Ochsner Clinic Foundation ( Site 0021), New Orleans
  • Louisiana State University Health Sciences Shreveport ( Site 0053), Shreveport
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06966700

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  • Mary Bird Perkins Cancer Center, Baton Rouge
  • University Medical Center - New Orleans, New Orleans
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05633654

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

  • LSU Health Sciences Center, Shreveport
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2025 · NCT06700070

CtDNA Based MRD Testing for NAC Monitoring in TNBC

  • Louisiana State University, New Orleans
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 7 Faoi 2025 · NCT06230185

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.